Reported Earlier, 89bio Prices Upsized $125M Public Offering Of 11,455,882 Common Stock At $8.50/Share And Pre-Funded Warrants
Reported Earlier, 89bio Prices Upsized $125M Public Offering Of 11,455,882 Common Stock At $8.50/Share And Pre-Funded Warrants
此前報道，89bio定價爲每股8.50美元的普通股以及預先融資認股權的12500萬美元的公開發行。
The gross proceeds of the offering to 89bio, before deducting the underwriting discounts and commissions and other offering expenses payable by 89bio, are expected to be approximately $125.0 million. The offering is expected to close on or about November 14, 2024, subject to the satisfaction of customary closing conditions
在扣除89bio支付的承銷折扣、佣金和其他發售費用之前，本次發行預計將獲得約1,2500萬美元的總收益。本次發行預計將於2024年11月14日左右結束，視情況以通常的結束條件爲準。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間